PXBioVisioN — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

PXBioVisioN is a specialized, service-oriented CRO leveraging over two decades of peptide research expertise to enable biomarker discovery and validation. The company's core offering is its peptidomics platform, which analyzes proteins and peptides to uncover biomarkers correlated with biological events and drug responses. By providing end-to-end services from study design to high-quality sample analysis, PXBioVisioN aims to de-risk and accelerate early-stage therapeutic development for its clients, primarily in the pharmaceutical and biotech sectors. It operates as a private, likely bootstrapped or privately funded entity, generating revenue through its analytical service contracts.

Ophthalmology

Technology Platform

Integrated peptidomics platform utilizing liquid chromatography and tandem mass spectrometry (LC-MS/MS) for the identification and quantification of peptides in complex biological samples, supported by standardized pre-analytical sample protocols and bioinformatics analysis.

Opportunities

The growing demand for biomarkers in drug development to de-risk clinical trials and demonstrate early proof-of-mechanism presents a significant opportunity.

Additionally, the expansion of the peptide therapeutics market creates a natural client base in need of specialized analytical services for pharmacokinetic and pharmacodynamic studies.

Risk Factors

Key risks include client concentration, reliance on a narrow technological niche (peptidomics) which could be supplanted by other methodologies, and competition from larger, full-service CROs that may develop or acquire similar capabilities.

Continuous investment in cutting-edge mass spectrometry is also required to avoid technological obsolescence.

Competitive Landscape

PXBioVisioN competes in the bioanalytical CRO segment, specifically within the niche of peptidomics and peptide biomarker services. Direct competitors include other specialized proteomics/peptidomics CROs and academic core facilities, while indirect competition comes from large, diversified CROs (like LabCorp, IQVIA, Charles River) with broad bioanalytical divisions. Its differentiation is its deep, focused expertise in peptide analysis from complex biological matrices.

More companies in Proteomics & Protein Engineering →More companies in Germany →